From Medscape Cardiology

Medscape Medical News from the:

American Heart Association (AHA) 2013 Scientific Sessions

November 16 - 20, 2013; Dallas, Texas

This coverage is not sanctioned by, nor a part of, the American Heart Association.

The Cardiology Show

AHA 2013: Top Trial Hits and Misses from Dr Valentin Fuster and Panel
This year's Cardiology Show tackles ENGAGE-AF, STREAM, COAG, CTSN-MR, TOPCAT, and EU-PACT, but prevention with a personal touch is the key, according to Dr Fuster and panelists Drs Mega, Ohman, Harrington, Robinson, and Yancy.

Meeting Highlights at a Glance

Top News From AHA 2013: Slideshow
Highlights include release of (and controversy) over the new ACC/AHA risk calculator, plus data from TOPCAT, CORAL, EU-PACT and COAG, ENGAGE-AF TIMI-48, and more.

Conference News

AHA Strategy Achieves Population-Wide Sodium Reduction
Medscape Medical News, December 5, 2013
AHA Coronary Artery Calcium Density May Help Predict CVD Risk
Heartwire from Medscape, November 25, 2013
AHA LV 'Augmentation' Implant: Promising (Very) Early Data
Heartwire from Medscape, November 25, 2013
AHA FFR Reclassifies 43% of Patients, Without Cutting PCI Rates
Heartwire from Medscape, November 22, 2013
AHA Plunging LDL-C Maintained Over a Year of Antibody Treatment
Heartwire from Medscape, November 21, 2013
AHA Bleeding With New Oral Anticoagulants Depends on Setting
Heartwire from Medscape, November 21, 2013
AHA Mixed Results With Pharmacogenetics to Guide Warfarin Dosing
Medscape Medical News, November 20, 2013
AHA Campaign Sustains Healthy Behaviors Among Preschoolers
Heartwire from Medscape, November 19, 2013
AHA Revascularization plus Exercise Eases Walk Pain in PAD
Heartwire from Medscape, November 19, 2013
AHA Poor Results With Ablation of AF Drivers in RADAR-AF
Heartwire from Medscape, November 19, 2013
AHA ENGAGE AF-TIMI 48: Edoxaban Noninferior to Warfarin in AF
Heartwire from Medscape, November 19, 2013
AHA 'Extraordinary' Chelation Effects in Diabetes: TACT
Heartwire from Medscape, November 19, 2013
AHA Plasma Apolipoprotein E Linked to Dementia Risk
Medscape Medical News, November 19, 2013
AHA TOPCAT: Aldo-Antagonist Falls Short but Impresses in HFPEF
Heartwire from Medscape, November 18, 2013
AHA CORAL: Stents No Benefit in Renal-Artery Stenosis
Heartwire from Medscape, November 18, 2013
AHA How Good Is the New ACC/AHA Risk Calculator?
Heartwire from Medscape, November 18, 2013
AHA VISTA-16 at Last: Investigators Allege Misconduct by Sponsor
Heartwire from Medscape, November 18, 2013
AHA Dopamine, Nesiritide Unhelpful in Kidney-Compromised AHF
Heartwire from Medscape, November 18, 2013
AHA Repair and Surgery Fare Equally Well in Ischemic MR
Heartwire from Medscape, November 18, 2013
AHA Brain-Computer Interface May Aid Stroke Recovery
Medscape Medical News, November 18, 2013
AHA Intense Approach Ups Pill Taking, but Not BP, Lipid Control
Heartwire from Medscape, November 18, 2013
AHA CATIS: No Benefit of BP Reduction in Acute Phase of Stroke
Medscape Medical News, November 17, 2013
AHA Postarrest Hypothermia Trials Disappoint and Tantalize
Heartwire from Medscape, November 17, 2013
AHA Nitrites No Cure for Reperfusion Injury From MI Stenting
Heartwire from Medscape, November 17, 2013
AHA Should Statins Be Used for Primary Prevention in Women?
Heartwire from Medscape, November 17, 2013
AHA Undiagnosed CVD Key Cause of Pregnancy-Related Deaths
Heartwire from Medscape, November 17, 2013
AHA AHA 2013: What's Going to Be Hot? (Long-Awaited Guidelines!)
Heartwire from Medscape, November 14, 2013

Medscape Cardiology© WebMD, LLC

Perspectives from AHA

What Can We Learn From a Negative Trial?
Shelley Wood;
Jessica L. Mega, MD, MPH;
E. Magnus Ohman, MD

Genotype-Guided Drug Therapy
Robert Harrington, MD, Jessica Mega, MD, MPH, E. Magnus Ohman, MD, Jennifer Robinson, MD

Dr. Clyde Yancy on Recent Heart Failure Studies
Melissa Walton-Shirley, MD;
Clyde W. Yancy, MD, MSc

The RADAR-AF Trial: Take Another Look
John M. Mandrola, MD;
Felipe Atienza, MD, PhD

Cholesterol Guidelines and CV Risk Calculator Clarifications
Clyde W. Yancy, MD, MSc;
Robert A. Harrington, MD;
Jennifer G. Robinson, MD

Lessons From the Resuscitation Sessions at AHA
Lance B. Becker, MD;
Graham Nichol, MD, MPH

Integrating Novel Oral Anticoagulants Into Clinical Practice
Samuel Z. Goldhaber, MD;
Seth Bilazarian, MD

COAG: Does Genetic Testing Help With Warfarin Dosing?
Samuel Z. Goldhaber, MD

Keeping Positive About Negative Trials at National Heart Meetings
Seth Bilazarian, MD

The Future for NOACs in Light of ENGAGE-AF
E. Magnus Ohman, MD;
Jessica L. Mega, MD, MPH

Guest Christian Ruff: ENGAGE-AF and NOAC Meta-analysis
Samuel Z. Goldhaber, MD;
Christian T. Ruff, MD, MPH

What Do CORAL and ERASE Mean for Peripheral Intervention?
Seth Bilazarian, MD;
Mark A. Creager, MD

Who's at Risk? A Defense of the CV Risk Calculator
Sidney C. Smith Jr, MD;
Shelley Wood

Bloggers from the Floor

STREAM: Reassurance that TNK Is Second Best
Melissa Walton-Shirley, MD

Women Are as Old as Their Microvasculature: 10 Years Post-Go Red

Stories of Tony, Jess, and Ileana: Opening Session AHA 2013

Is Mission: LifeLine's Mission Accomplished? 'Not just yet'

Fifty Years Past the Kennedy-Oswald Era: CPR Stands Still

Say It Isn't So . . . In the Treatment of Typical Atrial Flutter, Less May Not Be More
John M. Mandrola, MD

Chelation Therapy: Promising for Diabetic Patients but Disruptive to the Medical Establishment

Day 3 at AHA 2013: Top Seven EP Stories: AF Ablation, ICDs, CRT, Dabigatran, and Clinical Effectiveness Research

Portable Ultrasound as the Stethoscope of the Future: Is It the Snapchat of Formal Echocardiography?

AHA 2013 Day 1: Improving Survival in Cardiac Arrest—A worthy goal!

Previous Coverage

AHA 2012

AHA 2011

AHA 2010